N/A
N=15
Human Papillomatosis Genotyping of Children in Thailand
Recurrent Laryngeal Papillomatosis · Human Papilloma Virus
Bottom Line
View on ClinicalTrials.gov: NCT01304966 ↗Enrolled (actual)
15
Serious AEs
—
Results posted
Feb 2014
Primary outcome: Primary: Human Papillomavirus Genotypes — 6; 9 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- biopsy (Procedure)
- Age
- Pediatric, Adult
- Sex
- All
- Sponsor
- Queen Sirikit National Institute of Child Health
- Primary completion
- Sep 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Human Papillomavirus Genotypes |
6; 9 | — |
| SECONDARY Cotreta-Derkay Score |
13.83; 27.44 | 0.013 sig |
Summary
The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.
Eligibility Criteria
Inclusion Criteria
- Patients have active laryngeal papillomatosis .
- Patients have developed this infection before the age of 18 years old.
Exclusion Criteria
- Children whose families do not sign an informed consent to enter into study.
- Children whose families anticipate discontinuing care at a participating institution during the study period.
Data sourced from ClinicalTrials.gov (NCT01304966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.